Lab21 appoints Susan Lowther as Chief Financial Officer

29-Oct-2010 - United Kingdom

Lab21 Limited announced the appointment of Susan Lowther as Chief Financial Officer.

Susan brings a wealth of experience, gained over 20 years in the pharmaceutical, biotech and healthcare industries. She has extensive financial management expertise, gained from working with start up companies to global PLCs, covering both public and private financing, including venture capital financing and IPOs. Susan also has extensive experience of M&A activity, including acquisition and divestment.

Susan has held senior management positions at BioWisdom, RiboTargets, Lonza Biologics, Celltech and Monsanto.

Other news from the department people

Most read news

More news from our other portals

All FT-IR spectrometer manufacturers at a glance